Label: meclizine hydrochloride- Meclizine Hydrochloride tablet
-
Contains inactivated NDC Code(s)
NDC Code(s): 0591-0802-01, 0591-0803-01, 0591-0803-10 - Packager: Watson Laboratories, Inc.
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated March 28, 2006
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- N/A - Section Title Not Found In Database
-
DESCRIPTION
Meclizine HCl, an oral antiemetic, is a white, slightly yellowish, crystalline powder which has a slight odor and is tasteless. It has the following structural formula:
C25H27CIN2.2HCl.H2O 481.89
The chemical name is 1-(p-chloro-α-phenylbenzyl)-4-(m-methylbenzyl) piperazine dihydrochloride monohydrate.
Each tablet, for oral administration, contains 12.5 mg or 25 mg of Meclizine HCl. In addition, each tablet contains the following inactive ingredients: colloidal silicon dioxide, corn starch, D&C yellow # 10 lake (25 mg only), FD&C blue # 1 lake (12.5 mg only), lactose monohydrate, microcrystalline cellulose, povidone (12.5 mg only), sodium starch glycolate, and stearic acid.
-
ACTIONS
Meclizine HCl is an antihistamine which shows marked protective activity against nebulized histamine and lethal doses of intravenously injected histamine in guinea pigs. It has a marked effect in blocking the vasodepressor response to histamine, but only a slight blocking action against acetylcholine. Its activity is relatively weak in inhibiting the spasmogenic action of histamine on isolated guinea pig ileum. It has a slower onset and longer duration of action (24 hours) than most other antihistamines used for motion sickness.
Antihistamines have been observed to have both stimulant and depressant effects on the CNS, but no clear explanation exists in regard to their diverse central actions. The site and mode of their central action is unknown.
- INDICATIONS:
- CONTRAINDICATIONS
-
WARNINGS
Some drowsiness may, on occasion, occur with the use of this drug, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery.
Patients should avoid alcoholic beverages while taking this drug. Due to its potential anticholinergic action, this drug should be used with caution in patients with asthma, glaucoma, or enlargement of the prostate gland.
- USAGE IN PEDIATRIC PATIENTS
-
USAGE IN PREGNANCY
Pregnancy Category B. Reproduction studies in rats have shown cleft palates at 25-50 times the human dose. Epidemiological studies in pregnant women, however, do not indicate that meclizine increases the risk of abnormalities when administered during pregnancy. Despite the animal findings, it would appear that the possibility of fetal harm is remote. Nevertheless, meclizine, or any other medication, should be used during pregnancy only if clearly necessary.
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
-
HOW SUPPLIED
Meclizine HCl Tablets USP are supplied as follows:
12.5 mg: Blue/white, oval, bi-layer tablet debossed WATSON and 802 on one side and a partial bisect on the other side, in bottles of 100.
25 mg: Yellow/white, oval, bi-layer tablet debossed WATSON and 803 on one side and a partial bisect on the other side, in bottles of 100 and 1000.
Store at controlled room temperature 15°-30°C (59°- 86°F). Dispense in a well-closed container as defined in USP/NF.
Manufactured For:
Watson Laboratories, Inc.
Corona, CA 92880 USAManufactured by:
Patheon Pharmaceuticals Inc.
Cincinnati, OH 45215 USARev. 10/03
70010599 -
INGREDIENTS AND APPEARANCE
MECLIZINE HYDROCHLORIDE
meclizine hydrochloride tabletProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0591-0803 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Meclizine Hydrochloride (UNII: HDP7W44CIO) (Meclizine - UNII:3L5TQ84570) 25 mg Inactive Ingredients Ingredient Name Strength collidiol silicon dioxide () corn starch () D & C Yellow #10 lake () lactose monohydrate () microcrystalline cellulose () sodium starch glycolate () stearic acid (UNII: 4ELV7Z65AP) Product Characteristics Color WHITE (white) , YELLOW (yellow) Score no score Shape OVAL Size 13mm Flavor Imprint Code WATSON;803 Contains Coating false Symbol false Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0591-0803-01 100 in 1 BOTTLE 2 NDC:0591-0803-10 1000 in 1 BOTTLE MECLIZINE HYDROCHLORIDE
meclizine hydrochloride tabletProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0591-0802 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Meclizine Hydrochloride (UNII: HDP7W44CIO) (Meclizine - UNII:3L5TQ84570) 12.5 mg Inactive Ingredients Ingredient Name Strength collidiol silicon dioxide () corn starch () FD & C Blue #1 lake () lactose monohydrate () microcrystalline cellulose () povidone () sodium starch glycolate () stearic acid (UNII: 4ELV7Z65AP) Product Characteristics Color BLUE (Blue) , WHITE (white) Score no score Shape OVAL Size 13mm Flavor Imprint Code WATSON;802 Contains Coating false Symbol false Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0591-0802-01 100 in 1 BOTTLE Labeler - Watson Laboratories, Inc.